Is there in vivo-in vitro correlation between antifungal susceptibility, species of Candida spp. and clinical outcome?
Krcmery
V
V
University of Trnava, School of Public Health, 917 43 Trnava, Slovakia. vkrcmery@truni.sk
D000935:Antifungal Agents / Q000494:pharmacology* / Q000627:therapeutic use; D002175:Candida / Q000187:drug effects*; D002177:Candidiasis / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D015658:HIV Infections / Q000150:complications / Q000382:microbiology; D006801:Humans; D008826:Microbial Sensitivity Tests; D009369:Neoplasms / Q000150:complications / Q000382:microbiology; D013223:Statistics as Topic; D016896:Treatment Outcome; D014230:Triazoles / Q000494:pharmacology / Q000627:therapeutic use
D000935:Antifungal Agents; D014230:Triazoles